Petrelintide
Novo Nordisk\'s Long-Acting Amylin Analog
Petrelintide is Novo Nordisk\'s investigational long-acting amylin analog designed for once-weekly dosing. Amylin is a hormone co-secreted with insulin that naturally promotes fullness and slows gastric emptying. Petrelintide is being studied both as a standalone therapy and in combination with semaglutide (CagriSema-like approach) to potentially enhance weight loss outcomes beyond what either mechanism achieves alone. Use the Shotlee app to track your current protocol and build baseline data for whatever comes next.
What Is Petrelintide?
Petrelintide is Novo Nordisk\'s investigational long-acting amylin analog designed for once-weekly dosing. Amylin is a hormone co-secreted with insulin that naturally promotes fullness and slows gastric emptying. Petrelintide is being studied both as a standalone therapy and in combination with semaglutide (CagriSema-like approach) to potentially enhance weight loss outcomes beyond what either mechanism achieves alone.
Track your current protocol in Shotlee while this science evolves. Having clean historical data means you can compare outcomes with precision if you ever switch medications.
How It Works
Amylin Signaling
- • Mimics natural amylin hormone
- • Promotes satiety and fullness
- • Slows gastric emptying
- • Track appetite changes in Shotlee
Glucagon Suppression
- • Reduces post-meal glucagon
- • Stabilizes blood sugar
- • Complements insulin action
- • Log glucose data in Shotlee
Combination Potential
- • Being tested with semaglutide
- • Dual amylin + GLP-1 approach
- • May amplify weight loss
- • Track combo protocols in Shotlee
Why This Matters
As a long-acting amylin analog, Petrelintide attacks obesity through a different hormonal pathway than GLP-1 drugs. The combination with semaglutide could deliver some of the largest weight loss figures yet seen in clinical development.
Clinical Data
Petrelintide monotherapy showed approximately 9% weight loss over 26 weeks in Phase 2.
Studies combining petrelintide with semaglutide are in progress to evaluate enhanced efficacy.
Side Effects
- • Nausea (common with amylin analogs)
- • GI discomfort
- • Generally manageable
- • Log side effects in Shotlee
Vital Protocol FAQs
What is Petrelintide?
Petrelintide is Novo Nordisk\'s long-acting amylin analog for obesity. It works through the amylin hormone pathway rather than GLP-1. Track your amylin protocol in the Shotlee app.
How is it different from Cagrilintide?
Both are amylin analogs from Novo Nordisk, but petrelintide has a different pharmacological profile. Track your response to either in Shotlee for comparison data.
Prepare for Better Protocol Outcomes
Track your protocol with Shotlee and make every decision from clean, visible data instead of guesswork.
🚀 Use Shotlee for Free